| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/13/2008 | EP1414820B1 Non-nucleoside reverse transcriptase inhibitors |
| 02/13/2008 | EP1373234B1 Urokinase inhibitors |
| 02/13/2008 | EP1335747B1 A composition of sodium channel blocking compound |
| 02/13/2008 | EP1289507B1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 02/13/2008 | EP1207200B1 High affinity choline transporter |
| 02/13/2008 | EP1082126B1 Novel peptides |
| 02/13/2008 | CN201020128Y Health-care rhinobyon |
| 02/13/2008 | CN101124215A Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders |
| 02/13/2008 | CN101123985A Therapeutic agent for constipation |
| 02/13/2008 | CN101123966A Combination therapy comprising the use of ET-743 and doxorubicin for treating cancer |
| 02/13/2008 | CN101123963A Sabcomeline alone or combined with a mood stabilising or antimanic agent to treat bipolar disorders |
| 02/13/2008 | CN101121750A Humanized anti-erbb2 antidbodies and treatment with anti-erbb2 antibodies |
| 02/13/2008 | CN101121021A Humanized anti-ErbB2 antidbodies and treatment with anti-ErbB2 antibodies |
| 02/13/2008 | CN100368401C Cyanoguanidine prodrugs |
| 02/13/2008 | CN100368021C Ophthalmological anti proliferative medicine containing sodium alginate micro gel bead and convex membrane and preparing method |
| 02/13/2008 | CN100368014C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 02/13/2008 | CN100367960C Process for producing coated preparation |
| 02/13/2008 | CN100367946C Gabapentin analogues for fibromy algia and other disorders |
| 02/12/2008 | US7329795 Screening substances promoting or suppressing response to mycobacterial lipoproteins/lipopeptides by contacting peritoneal macrophages isolated from transgenic toll-like receptor 1 inactivated mouse with the substance and comparing the response to that using macrophages from a control mouse |
| 02/12/2008 | US7329749 Piperazinylcarbonylquinolines and -isoquinolines |
| 02/12/2008 | US7329734 Comprises recombinant insulin like growth factor receptor interacting protein for use in identifying modulators for treatment and prevention of cell proliferative disorders |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329666 Antitumor agents |
| 02/12/2008 | US7329649 Combinatorial methods for inducing cancer cell death |
| 02/12/2008 | US7329423 Compositions comprising thylakoids useful in the modulation of inflammation process |
| 02/12/2008 | US7329406 Methods of treating psoriasis with αvβ3-specific antibodies |
| 02/12/2008 | CA2427583C Inhalable formulation of a solution containing a tiotropium salt |
| 02/12/2008 | CA2402405C Compositions containing alpha-2-adrenergic agonist components |
| 02/12/2008 | CA2387018C Chemokine receptor |
| 02/12/2008 | CA2373473C Electrolyte gels for maintaining hydration and rehydration |
| 02/12/2008 | CA2317793C Laxative composition |
| 02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |
| 02/12/2008 | CA2294582C Treatment of diabetes with thiazolidinedione and metformin |
| 02/12/2008 | CA2238548C Composition and method for alleviating impaired mental function and memory loss in mammals |
| 02/12/2008 | CA2174236C Superoxide dismutase and mimetics thereof |
| 02/12/2008 | CA2172778C Cgrp antagonist used for the treatment of lichen and pruritus; composition thus produced |
| 02/07/2008 | WO2008016842A1 Topical skin compositions, their preparation, and their use |
| 02/07/2008 | WO2008016793A2 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 02/07/2008 | WO2008016187A1 Pladienolide target molecule, compound capable of binding to the target molecule, and screening method for the compound |
| 02/07/2008 | WO2008016171A1 Prophylactic/therapeutic agent for renal dysfunction |
| 02/07/2008 | WO2008016118A1 Agent targeting dopamine receptor and screening method therefor |
| 02/07/2008 | WO2008016095A1 PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT |
| 02/07/2008 | WO2008016007A1 METALLO-β-LACTAMASE INHIBITOR |
| 02/07/2008 | WO2008016006A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 02/07/2008 | WO2008016002A1 AMYLOID β PRODUCTION REGULATOR CONTAINING PROTON PUMP INHIBITOR |
| 02/07/2008 | WO2007143483A3 Combination of pazopanib and lapatinib for treating cancer |
| 02/07/2008 | WO2007135547A3 Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis |
| 02/07/2008 | WO2007135518A3 Use of choline-based preparations for the treatment of tinnitus |
| 02/07/2008 | WO2007133796A3 Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist |
| 02/07/2008 | WO2007106432A3 Egf receptor phosphorylation status for disease treatment |
| 02/07/2008 | WO2006130627A3 Methods for treating hepatitis c |
| 02/07/2008 | US20080033204 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 02/07/2008 | US20080033061 Cation conducting gabaa receptors and their use |
| 02/07/2008 | US20080033060 Use Of A Compound Modulating At Least One Receiver Selected In A Group Comprising An Interleukin 8 Type B Receptor And Pacap-1 Receptor For Porparing A Pharmaceutical Composition For Rosacea Treatment |
| 02/07/2008 | US20080033058 Personal care compositions that deposit hydrophilic benefit agents |
| 02/07/2008 | US20080033028 Such as (+/-)-[9-(4-chlorobenzyl)-6-fluoro-8-methanesulfonyl-2, 3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid; prostaglandin receptor antagonists; antihistamines; nasal decongestion, rhinitis |
| 02/07/2008 | US20080033009 Solid Pharmaceutical Formulation |
| 02/07/2008 | US20080033001 Derivatives of Variolin B |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032966 Small Molecule Inhibitors of Mrp1 and Other Multidrug Transporters |
| 02/07/2008 | US20080032961 Therapy employing LXRalpha modolators |
| 02/07/2008 | US20080032948 administering folic acid, methylmalonic acid lowering agent (vitamin B12, hydroxycobalamin, cyano-10-chlorocobalamin, aquocobalamin perchlorate, aquo-10-cobalamin perchlorate, azidocobalamin, cobalamin, cyanocobalamin, or chlorocobalamin), then pemetrexed disodium |
| 02/07/2008 | US20080032937 Bioavailability and Improved Delivery of Alkaline Pharmaceutical Drugs |
| 02/07/2008 | US20080032918 Gene expression or biosynthesis inhibition by locally administering inhibitors of angiotensin-converting enzyme, angiotensin type 1 receptors, or sodium-hydrogen exchange type-1 proteins; antiinflammatory agents, myocardial antiischemic agents, anaphylaxis; sustained release implants, stents, inhalers |
| 02/07/2008 | US20080032385 Novel antimicrobial peptide isolated from Penaeus monodon |
| 02/07/2008 | US20080032336 Chemokine receptor materials and methods |
| 02/07/2008 | US20080032320 Method of Screening Compound Capable of Accelerating or Inhibiting Apoptosis, Apoptosis Accelarator and Apoptosis Inhibitor |
| 02/07/2008 | US20080031975 Copper lowering treatment of inflammatory and fibrotic diseases |
| 02/07/2008 | US20080031963 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| 02/07/2008 | US20080031962 Microencapsulation of Cells in Hydrogels Using Electrostatic Potentials |
| 02/07/2008 | US20080031936 Immunostimulatory nucleic acid molecules |
| 02/07/2008 | US20080031886 Viruses for the treatment of cellular proliferative disorders |
| 02/07/2008 | US20080031880 Use of ErbB receptor ligands in treating diabetes |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031859 Central nervous system neural progenitor cell which induces synapse-forming neurons in the spinal cord |
| 02/07/2008 | US20080031854 Thiolated macromolecules and methods of making and using thereof |
| 02/07/2008 | US20080031851 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders |
| 02/07/2008 | DE102006038224A1 Procedure for the determination of neuroendocrinal health disorders such as e.g. chronic fatigue syndrome, comprises measuring glucocorticoids, sex steroids and amino acids/neurotransmitter and/or their metabolites in body fluids |
| 02/07/2008 | DE102006036373A1 Medicament, useful e.g. for the avoidance or alleviation of a poisoning by large clostridial cytotoxins and to combat Clostridium difficile infection, comprises inhibitor or activator of protease activity of clostridial cytotoxin |
| 02/07/2008 | CA2658340A1 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 02/06/2008 | EP1884568A1 Method for identification of compound having antidepressant effect |
| 02/06/2008 | EP1884520A2 Daptomycin analogs as antibacterial agents |
| 02/06/2008 | EP1884247A2 Gastrin compositions and formulations, and methods of use and preparation |
| 02/06/2008 | EP1883637A2 Non-nucleotide composition and method for inhibiting platelet aggregation |
| 02/06/2008 | EP1883452A2 Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone |
| 02/06/2008 | EP1883412A1 Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy |
| 02/06/2008 | EP1883302A2 Jak kinase inhibitors and their uses |
| 02/06/2008 | EP1059883B1 Integrated poration, harvesting and analysis device, and method therefor |
| 02/06/2008 | CN101119748A Pharmaceutical composition for treatment of diabetes |
| 02/06/2008 | CN101119747A Tissue factor production inhibitor |
| 02/06/2008 | CN101119718A Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 02/06/2008 | CN101117644A Diagnostics and therapeutics for glaucoma |
| 02/06/2008 | CN101116743A Cold treating medicine |
| 02/06/2008 | CN100366294C Oral cavity quick dissolving preparation and production method thereof |
| 02/06/2008 | CN100366293C Inhibitors of complement activation |
| 02/06/2008 | CN100366289C Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 02/06/2008 | CN100366257C Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 02/06/2008 | CN100366255C Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents |
| 02/06/2008 | CN100366248C Skin care composition for mediating cell to cell communication |
| 02/06/2008 | CN100366244C Local used composition containing antifungal agent |